Aliskiren Tablet, Film Coated
Product Images NDC 66993-141

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Aliskiren (NDC 66993-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Aliskiren Tablets 1)

Chemical structure diagram of aliskiren hemifumarate, the active ingredient in Aliskiren. The image shows the molecular structure with chemical bonds and components depicted clearly.*

FDA Label Image

Figure 1 (Aliskiren Tablets 2)

A chart illustrating the impact of co-administered drugs on the pharmacokinetics of aliskiren. It shows fold changes and 90% confidence intervals of Cmax and AUC for various interacting drugs, categorized into CYP3A4/P-gp inhibitors, antihypertensives, and others. Recommendations for dose adjustment or avoidance are noted beside each drug.*

FDA Label Image

Figure 2 (Aliskiren Tablets 3)

A pharmacokinetic impact graph showing the fold change and 90% confidence intervals of co-administered drugs when taken with aliskiren. The chart categorizes interacting drugs into antihypertensives and others, listing specific drugs with their doses and pharmacokinetic parameters (Cmax, AUC). It also includes recommendations regarding dose adjustments, with all listed drugs indicating no dose adjustment needed.*

FDA Label Image

150 mg Label (Aliskiren Tablets 4)

Aliskiren Tablets 150 mg film-coated tablets in a package of 30 tablets. The label includes the NDC 66993-141-30 and states the product is prescription only. The labeler is Prasco Laboratories, Mason, OH.*

FDA Label Image

300 mg Label (Aliskiren Tablets 5)

Aliskiren Tablets 150 mg film-coated oral tablets packaging label from Prasco Laboratories. The label indicates a 30-tablet package with prescription-only status. It includes storage instructions, manufacturer and distributor information, and a barcode.*

FDA Label Image

Aliskiren Tablets 6

Aliskiren Tablets 300 mg tablet film-coated bottle label by Prasco Laboratories. The product contains 30 tablets for oral use, prescription only. Label includes storage instructions and manufacturer details from Prasco Laboratories, Mason, OH USA, with NDC 66993-142-30.*

FDA Label Image

Aliskiren Tablets 7

Packaging label for Aliskiren Tablets 300 mg film-coated tablets by Prasco Laboratories. The label includes the NDC 66993-142-30, quantity of 30 tablets, and storage instructions. The drug is for prescription use only and intended for oral administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.